Sofinnova Closes $312M 7th Fund; Bets on Life Sciences
By Cormac Sheridan
Wednesday, December 12, 2012
Europe's cash-starved biotechnology sector has another €240 million (US$312 million) to aim for, following Sofinnova Partners' successful closing of its seventh fund.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.